The Taiwanese pharmaceutical market to reach USD 5.5 billion by 2018

40 %
60 %
Information about The Taiwanese pharmaceutical market to reach USD 5.5 billion by 2018
Business & Mgmt

Published on March 7, 2014

Author: researchonglobalmarkets

Source: slideshare.net

Description

For the complete report ,visit us at: http://bit.ly/taiwan-pharmaceutical

Or, get in touch with us at : support@researchonglobalmarkets.com

Abstract:
Taiwan Pharmaceutical Market Outlook 2013
Summary
GBI Research, the leading business intelligence provider, has released its latest research "Taiwan Pharmaceutical Market Outlook 2013". The report focuses on the Taiwanese pharmaceutical market, providing market analysis and a forecast to 2018. It provides details on the various market drivers and healthcare trends that influence growth in Taiwans pharmaceutical industry. The report also profiles major biopharmaceutical companies in the country, both domestic and overseas players.
Taiwans pharmaceutical market was worth $4.4 billion in 2012, having grown at a CAGR of 2.9%, and is estimated to reach $5.5 billion by 2018, growing at a CAGR of 3.9%. Although the size of the market is small compared with other growing markets in Asia, it is expected to provide a market entry point for companies wishing to launch their products in other larger markets.
Scope
- Political, economic and investment environment in Taiwan
- Healthcare and insurance system, healthcare infrastructure and key policy initiatives
- Market size estimation, analysis of key therapeutic areas and emerging areas
- Profiles of major biopharmaceutical companies in Taiwan, such as Pfizer, Sanofi Aventis, GSK and Novartis, and key domestic players such as China Chemical & Pharmaceutical Company, Standard Chemicals & Pharmaceuticals and Yung Shin Pharmaceutical.
- Key drivers and barriers that have had a significant impact on the market

Table of Contents:
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 9
2 Taiwan Pharmaceutical Market Outlook 2013 - Introduction 11
2.1 Taiwan Pharmaceutical Market 11
3 Taiwan Pharmaceutical Market Outlook 2013 - Investment Environment 12
3.1 Government and Political Environment 12
3.2 Taiwan Economic Outlook 12
3.3 Foreign Trade and Investment 14
3.4 Investment Incentives - Government Boosting the Biotech Sector 16
3.4.1 Act for the Development of Biotech and New Pharmaceuticals Industry (2007) 16
3.4.2 Diamond Action Plan for Biotechnology Takeoff (2009) 16
3.5 International Appraisal and Membership 17
3.5.1 Patent Prosecution Highway Pilot program 17
3.5.2 Pharmaceutical Inspection Convention and Inspection Cooperation Scheme 17
4 Taiwan Pharmaceutical Market Outlook 2013 - Healthcare System 18
4.1 Healthcare System 18
4.1.1 Department of Health 18
4.1.2 Bureau of National Health Insurance 19

Report: Taiwan Pharmaceutical Market Outlook 2013 Category: Healthcare Insert Image Height - 3.60 Width – 4.98 www.researchonglobalmarkets.com

Report: Taiwan Pharmaceutical Market Outlook 2013 Report Insights • Taiwan's pharmaceutical market was worth USD 4.4 billion in 2012 having grown at a CAGR of 2.9% • It is estimated to reach USD 5.5 billion by 2018, growing at a CAGR of 3.9% • Although the size of the market is small compared with other growing markets in Asia, it is expected to provide a market entry point for companies wishing to launch their products in other larger markets www.researchonglobalmarkets.com

Report: Taiwan Pharmaceutical Market Outlook 2013 Report Coverage • Political, economic and investment environment in Taiwan • Healthcare and insurance system, healthcare infrastructure and key policy initiatives • Market size estimation, analysis of key therapeutic areas and emerging areas • Profiles of major biopharmaceutical companies in Taiwan, such as Pfizer, Sanofi Aventis, GSK and Novartis, and key domestic players such as China Chemical & Pharmaceutical Company, Standard Chemicals & Pharmaceuticals and Yung Shin Pharmaceutical • Key drivers and barriers that have had a significant impact on the market www.researchonglobalmarkets.com

Report: Taiwan Pharmaceutical Market Outlook 2013 Report Benefits • Identify potential therapeutic areas in Taiwan that are poised for growth • Build effective market entry and expansion strategies for introducing products in Taiwan • Develop key strategic initiatives by studying top competitors key strategies • Reinforce R&D pipelines by identifying new target mechanisms that can produce first-in-class molecules with more efficacy and better safety www.researchonglobalmarkets.com

Report: Taiwan Pharmaceutical Market Outlook 2013 Table of Contents • Introduction • Investment Environment • Healthcare System • Regulatory Landscape • Market Overview • Competitive Landscape • Market Dynamics • The Way Forward • Appendix www.researchonglobalmarkets.com

Report: Taiwan Pharmaceutical Market Outlook 2013 Report Details • • • • • • • • • Publish date: 3rd Jun, 2013 Number of slides: 128 Geographic coverage: Global Available format: PDF, CD, Hardcopy Price for Single User License: USD 3,500 Price for Site License: USD 7,000 Price for Global User License: USD 10,500 Delivery Time: Within 1 business day Payment Modes: Credit/Debit Card, RTGS/Wire Transfer, Google Wallet, PayPal www.researchonglobalmarkets.com

Interested in this report? To view more details regarding this premium market research report, Please click here For further information, get in touch with us: E-mail: support@researchonglobalmarkets.com Call: US: +1 866 325 7446 UK: +44 203 514 2363 Others: +91 22 4098 7600 About Us Research on Global Markets is a leading source for market research on various sectors globally offering premium research content from worldwide publishers of market research reports Industry Segments Automotive & Transport Consumer goods Agriculture Food and Beverage Energy and Utilities Public Sector Manufacturing & Construction Healthcare Media & Entertainment IT, Telecom & Electronics Services Others www.researchonglobalmarkets.com

Add a comment

Related presentations

Related pages

The Taiwanese pharmaceutical market to reach USD 5.5 ...

Title: The Taiwanese pharmaceutical market to reach USD 5.5 billion by 2018, Author: Research on Global Markets, Name: ...
Read more

The Taiwanese pharmaceutical market to reach USD 5.5 ...

Report: South Korea Pharmaceutical Market Outlook 2013 Report Insights • The South Korean pharmaceutical market is the 10th largest pharmaceutical market ...
Read more

Taiwan Pharmaceutical Market Outlook 2013 - giiresearch.com

USD 3500 PDF by E -mail (Single user ... The report focuses on the Taiwanese pharmaceutical market, ... Taiwan's Pharmaceutical Market Expected to Reach $5 ...
Read more

市場調査レポート: 台湾の医薬品市場の見通し

USD 3,500 換算 369,215円 ... The report focuses on the Taiwanese pharmaceutical market, ... Taiwan's Pharmaceutical Market Expected to Reach $5.5 ...
Read more

台灣的醫藥品市場預測 - GII

USD 7,000 PDF by E -mail (Site license) ... The report focuses on the Taiwanese pharmaceutical market, ... Taiwan's Pharmaceutical Market Expected to Reach ...
Read more

Research and Future Development Trend Forecast of China ...

And it is estimated to reach USD 24.5 billion by 2018. ... High Barriers to Entry and Market Scale is about CNY 1.2 Billion ... 7.5.5. Future Development ...
Read more

Research and Future Development Trend Forecast of China ...

And the gaps of market concentration ratio are large due to the different regional operating... Home; Categories; About Us; Blog; Charity; Contact Us ...
Read more

PPT – Taiwan Insurance Market report Q2 2014 PowerPoint ...

Pharmaceutical Market Outlook in Taiwan 2013 ... It is estimated to reach USD 5.5 billion by 2018, ... "Taiwan Insurance Market report Q2 2014" is ...
Read more

News - vietnamm&a - Google Sites

Pharmaceutical Market: ... in Vietnam is more than US$5.5 billion, ... showed that the country attracted 5.7 billion USD in disbursed ...
Read more